ClinicalTrials.gg
RecruitingNCT05199896TOOL_TOUCHUpdated Mar 24, 2026

Touching the World With a Cane: Cognitive and Neural Processes

An interventional study of Behavioral protocol and EEG protocol in Visual Impairment and Healthy, sponsored by Hospices Civils de Lyon. Recruiting at 1 site in France. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-24.

Sponsored by Hospices Civils de Lyon · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Started Apr 2022; still recruiting 4 years 6 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
300
Allocation
Non-randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

The use of tools is ubiquitous in our lives and allows us to expand the sensorimotor capacities of our body. Much research has been done on the subject in sighted people over the past decades. This work has mainly focused on the motor aspect of using the tool, neglecting the sensory aspect. However, any action involving a tool carries sensory information, for example in the use of the white cane by blind people. 26% (> 200,000) of blind people in France use a white cane to get around. By sweeping the cane on the ground, they use it as a sensorimotor extension of their body to extract information from the environment in order to locate a pedestrian crossing or possible obstacles. While it is well established that the tools increase the user's motor skills, we have only just begun to clarify how they also function as sensory extensions of the user's body and how this phenomenon is potentially dependent on constant use of the tool to compensate for a missing sense, as is the case with blind people using a cane. The aim of this study is to fill this important gap in our knowledge.

02

Conditions studied

  • Visual Impairment
  • Healthy

Browse trials for

Keywords

  • Blind/Non-sighted
  • Healthy subject
  • fMRI
  • EEG
03

In context

Vision Disorders

360 studies on the registry are indexed under Vision Disorders; 84 are open to participants now.

This study's planned enrollment of 300 is above the median of 78 across 244 interventional studies indexed under Vision Disorders.

Browse Vision Disorders studies →

Lead sponsor

Hospices Civils de Lyon is the lead sponsor of 1,866 studies on the registry; 448 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Man or woman, aged 18 to 60 years old
  • Give an by signature
  • Be part of the national health security system (registered to the Securité Sociale)
  • do not confuse his right and his left

Specific of the non-sighted participants:

  • Loss of vision happened at birth or 3-to 5 years later minimum in life
  • Must have a visual acuity inferior or equal to 4/10
  • Be with a close relation for read information letter and sign the consent form if needed

Exclusion criteria

Exclusion Criteria:

  • A person presenting an history of neurological, psychiatric or linguistic problems cannot be admitted
  • Assumption of psychotropic drugs
  • Pregnancy or breast-feeding woman
  • A person under legal tutoring
  • A person under care in other medical structure for reasons different from those of this research
  • A person under administrative or judiciary contention
  • A person who is not eligible to a MRI-exam according to the following criteria cannot be admitted to the experiments including MR acquisitions :

    • Have a neurological, cardiac (battery) or defibrillator pacemaker
    • Have a cardiac prosthesis (valve, stent...) or vascular prosthesis
    • Have intracranial clips or clamps
    • Carry a bypass of the cerebrospinal fluid
    • Having metallic splinters in the eyes
    • Wear metal prostheses (teeth, knees)
    • Wear an infusion pump or system
    • Be claustrophobic or have respiratory problems
    • Have metal tattoos close to the head
    • Have permanent make-up
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
300 participants (estimated)

Study arms

  • Experimental
    All protocols (behavioral and EEG and fMRI)

    If participants accepts (non-sighted participants and Healthy volunteers), they will carry out the behavioral protocol and the EEG protocol and fMRI protocol.

    Behavioral: Behavioral protocol · Device: EEG protocol · Device: fMRI protocol

  • Experimental
    Behavioral protocol and EEG protocol

    Participants who agree to participate in only one of the experiments (EEG or MRI) will be assigned to either the EEG or fMRI type of study in each subgroup. All participants (non-sighted participants and Healthy volunteers) will do the behavioral session and at least one EEG or MRI session.

    Behavioral: Behavioral protocol · Device: EEG protocol

  • Experimental
    Behavioral protocol and fMRI protocol

    Participants who agree to participate in only one of the experiments (EEG or MRI) will be assigned to either the EEG or fMRI type of study in each subgroup. All participants (non-sighted participants and Healthy volunteers) will do the behavioral session and at least one EEG or MRI session.

    Behavioral: Behavioral protocol · Device: fMRI protocol

Interventions

  • BehavioralBehavioral protocol

    A touch sensitive computer screen either displaying a downscaled (45cm long) image of the rod (for the sighted), or supporting a same sized wooden rod (for the blind), will be placed on the table in front of the participant to record their localization performance. They will be instructed to use their left index fingertip to indicate on the image of the screen (for sighted) or on the wooden rod (for the blind) the position where they have felt the touch provided to the 90 cm long they held in their right dominant hand. Participants will wear a headset playing white noise to prevent any auditory localization cues when the long rod will be touched. The rod will be touched by a computer controlled solenoid. Thus, participants will respond with a hand gesture on the image or rod and will be asked to validate the position by pressing a foot-pedal with their left foot.

  • DeviceEEG protocol

    The EEG protocol will be similar as the behavioral one described above, with the distinction of taking place in two separate sessions: one where the rod are touched, and one where their hand is touched. The participant will hold a rod in each hand and he will have to indicate on which rod he felt the touch. Additionally electrophysiological responses will be continuously recorded using a 65 channel ActiCap system (Brain Products).

  • DevicefMRI protocol

    The same behavioral task and procedures of the behavioral protocol described above will be applied, adapted to take into account the constraints posed by the magnetic environment of the MR scanner. The participant will be placed on the scanner bed and provided with earphones that will both protect against the noise of the machine (80dB) and ensure a continuous communication with the participant. During the fMRI sessions, the participant will solve the same rod localization behavioral task while we will record brain activations by measuring the brain oxygen level dependent signal via Echo Planar Imaging sequences. We will use an MRI compatible tactile stimulator to touch the hand-held rod and participants location judgement will be recorded by using an MRI-compatible tablet, positioned on their abdomen, where the participant will have to indicate the judged position.

06

What researchers measure

Primary outcomes

  1. Perceived location

    Tactile stimulus will be applied on a tool (a rod). Subject should determine the exact spatial location of the stimulus. This will be measure at each stimulation.

    Time frame: 90 minutes

Secondary outcomes

  1. Brain activity

    Brain oscillatory activity and the somatosensory evoked potentials during the realization of experimental tasks on EEG. Two sessions of about 3 hours are necessary for the EEG acquisition.

    Time frame: 6 hours

  2. Brain activity

    Measuring the brain oxygen level dependent (BOLD) signal during the realization of experimental tasks on fMRI

    Time frame: 3 hours

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05199896
Responsible party
Sponsor
First posted
Jan 20, 2022
Start date
Apr 20, 2022
Primary completion
Oct 2028 (estimated)
Completion
Oct 2028 (estimated)
Last update
Mar 24, 2026

Study contacts

Alessandro FARNE, Dr
Contact
alessandro.farne@inserm.fr
04 72 91 34 17 ext. +33
Cécile FABIO
Contact
cecile.fabio@inserm.fr

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion